Most lawyers begin learning about torts by reading the Palsgraf case. Palsgraf established the principle of foreseeability as the basis for imposing a duty. But are the principles from Palsgraf still relevant today?
The Product Liability & Mass Torts Blog, published by ArentFox Schiff LLP, focuses on legal developments and issues related to product liability and mass tort litigation. It covers topics such as public nuisance claims in mass torts, regulatory and litigation challenges involving pharmaceuticals and consumer products, personal jurisdiction in product liability cases, and the impact of recent court decisions on tort law. The blog also addresses practical considerations for businesses facing product liability risks, including compliance and litigation strategies. It provides analysis of trends affecting manufacturers, distributors, and retailers involved in mass tort and product liability disputes.
Generic pharmaceutical drugs are versions of brand-name counterparts with one major difference: they typically cost a lot less. By FDA regulation, the two have the same active ingredients, dosage forms and strengths, and routes of administration.[1] And while federal…